Screener
Business Segments12 metrics
AB-101-001 Phase 1a/1b clinical trial expenseConsolidated net lossGain on sale of property and equipmentG&AImdusiran IM-PROVE I, II & III clinical trials expenseInterest IncomeNet Income (Loss)Other early research and development programs expenseOther segment expenseRestructuring costsRevenueSegment Reporting Information, Profit (Loss)